Juvenile Myositis clinical trials at UCSF
1 research study open to eligible people
Juvenile myositis is an illness that makes a child's muscles weak and sore. UCSF is studying a new medication in children with active disease to test safety and muscle response. UCSF is recording muscle exams and lab results before and after treatment.
Showing trials for
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
open to eligible people ages 6-75
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
San Francisco, California and other locations
Our lead scientists for Juvenile Myositis research studies include Susan Kim, MD, MMSc.
Last updated: